- Home
- CGEM vs ERII Comparison
CGEM vs ERII Comparison
Compare CGEM & ERII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- ERII
- Stock Information
- Founded
- CGEM 2016
- ERII 1992
- Country
- CGEM United States
- ERII United States
- Employees
- CGEM N/A
- ERII N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- ERII Industrial Machinery/Components
- Sector
- CGEM Health Care
- ERII Technology
- Exchange
- CGEM Nasdaq
- ERII Nasdaq
- Market Cap
- CGEM 730.2M
- ERII 851.0M
- IPO Year
- CGEM 2021
- ERII 2008
- Fundamental
- Price
- CGEM $8.46
- ERII $14.77
- Analyst Decision
- CGEM Strong Buy
- ERII Strong Buy
- Analyst Count
- CGEM 7
- ERII 4
- Target Price
- CGEM $32.50
- ERII $20.75
- AVG Volume (30 Days)
- CGEM 420.6K
- ERII 244.0K
- Earning Date
- CGEM 03-13-2025
- ERII 02-26-2025
- Dividend Yield
- CGEM N/A
- ERII N/A
- EPS Growth
- CGEM N/A
- ERII 22.95
- EPS
- CGEM N/A
- ERII 0.33
- Revenue
- CGEM N/A
- ERII $135,062,000.00
- Revenue This Year
- CGEM N/A
- ERII $15.22
- Revenue Next Year
- CGEM N/A
- ERII $9.76
- P/E Ratio
- CGEM N/A
- ERII $44.58
- Revenue Growth
- CGEM N/A
- ERII 19.05
- 52 Week Low
- CGEM $8.36
- ERII $12.26
- 52 Week High
- CGEM $30.19
- ERII $20.27
- Technical
- Relative Strength Index (RSI)
- CGEM 27.85
- ERII 48.22
- Support Level
- CGEM $8.35
- ERII $14.58
- Resistance Level
- CGEM $9.51
- ERII $14.98
- Average True Range (ATR)
- CGEM 0.46
- ERII 0.38
- MACD
- CGEM -0.08
- ERII -0.00
- Stochastic Oscillator
- CGEM 11.91
- ERII 27.10
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.
About ERII Energy Recovery Inc.
Energy Recovery Inc is an engineering-driven technology company. It is engaged in engineering, designing, manufacturing and supplying solutions that make industrial processes more efficient and sustainable. The company operates in three segments, Water, Emerging Technologies and Corporate. It offers energy recovery devices (ERDs) and pumps as well as related products and services to the global reverse osmosis desalination market. The company derives a majority of the revenue from the Water segment. Geographically, the company operates in the U.S. and other international countries.